Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways

AIM: Loss of skeletal muscle mass is a common clinical finding in cancer patients. The purpose of this meta‐analysis and systematic review was to quantify the effect of doxorubicin on skeletal muscle and report on the proposed molecular pathways possibly leading to doxorubicin‐induced muscle atrophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiensch, Anouk E., Bolam, Kate A., Mijwel, Sara, Jeneson, Jeroen A. L., Huitema, Alwin D. R., Kranenburg, Onno, van der Wall, Elsken, Rundqvist, Helene, Wengstrom, Yvönne, May, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317437/
https://www.ncbi.nlm.nih.gov/pubmed/31600860
http://dx.doi.org/10.1111/apha.13400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317437/
https://www.ncbi.nlm.nih.gov/pubmed/31600860
http://dx.doi.org/10.1111/apha.13400

Ejemplares similares